Immuron (IMRN) Inventory Average (2017 - 2025)
Immuron's quarterly Inventory Average came in at $576401.9 in Q3 2025, up 8.74% year-on-year from $530070.8 in Q3 2024, and down 45.8% quarter-over-quarter from $1.1 million in Q2 2025.
Immuron has reported Inventory Average for 9 years, with the latest figure at $576401.9 in Q3 2025.
- For the quarter ending Q3 2025, Inventory Average rose 8.74% year-over-year to $576401.9; the trailing twelve-month figure through Sep 2025 stood at $576401.9 (up 8.74% YoY), and the FY2025 full-year result was $583222.0, up 10.55% from the prior year.
- Inventory Average for Q3 2025 stood at $576401.9, down from $1.1 million in the prior quarter.
- The five-year high for Inventory Average was $1.2 million in Q4 2021, with the low at $286798.9 in Q3 2023.
- Average Inventory Average over 5 years is $598127.7, with a median of $528745.4 recorded in 2024.
- Year-over-year, Inventory Average surged 191.89% in 2021 and plunged 47.85% in 2022.
- Tracing IMRN's Inventory Average over 5 years: stood at $1.2 million in 2021, then plunged by 47.85% to $647101.5 in 2022, then slumped by 37.41% to $404998.8 in 2023, then gained by 24.41% to $503871.0 in 2024, then grew by 14.39% to $576401.9 in 2025.
- The last three Inventory Average figures came in at $576401.9 (Q3 2025), $1.1 million (Q2 2025), and $503871.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | 576,401.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 576,401.87 |
| Jun 30, 2025 | 1.06 Mn |
| Dec 31, 2024 | 503,870.97 |
| Sep 9, 2024 | 530,070.78 |
| Jun 30, 2024 | 527,419.94 |
| Dec 31, 2023 | 404,998.85 |
| Sep 28, 2023 | 405,824.88 |
| Aug 30, 2023 | 286,798.92 |
| Jun 30, 2023 | 595,064.60 |
| Dec 31, 2022 | 647,101.50 |
| Aug 31, 2022 | 337,522.27 |
| Jun 30, 2022 | 466,139.46 |
| Dec 31, 2021 | 1.24 Mn |
| Jun 30, 2021 | 788,171.25 |
| Dec 31, 2020 | 869,786.25 |
| Sep 1, 2020 | 1.12 Mn |
| Jun 30, 2020 | 270,022.98 |
| Dec 31, 2019 | 199,259.63 |
| Jun 30, 2019 | 1.28 Mn |
| Dec 31, 2018 | 1.88 Mn |
| Sep 27, 2018 | 1.88 Mn |
| Aug 30, 2018 | 1.91 Mn |
| Jun 30, 2018 | 1.73 Mn |
| Dec 31, 2017 | 1.83 Mn |
| Sep 28, 2017 | 2.09 Mn |
| Aug 31, 2017 | 2.05 Mn |
| Jun 30, 2017 | 1.65 Mn |